COLLEGIUM PHARMACEUTICAL, INC (COLL)
Collegium Announces $50 Million Accelerated Share Repurchase Program
CORMEDIX INC. (CRMD)
Cormedix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
ASCENDIS PHARMA A/S (ASND)
Ascendis Pharma Reports Second Quarter 2026 Financial Results
BRAGG GAMING GROUP INC. (BRAG)
Bragg Gaming Group Reports Second Quarter 2026 Financial Results
RIO TINTO PLC (RIO)
Rio2 Reports Q2 2026 Financial and Operating Results and Webinar
MINK THERAPEUTICS, INC. (INKT)
MiNK Therapeutics Reports Second Quarter 2026 Financial Results and Reports Observations from Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury
CREATIVE REALITIES, INC. (CREX)
Creative Realities Reports Fiscal 2026 Second Quarter Results
KARYOPHARM THERAPEUTICS INC. (KPTI)
Karyopharm Reports Second Quarter 2026 Financial Results and Highlights Continued Progress Toward Myelofibrosis sNDA Submission
MADISON SQUARE GARDEN SPORTS CORP. (MSGS)
Madison Square Garden Sports Corp. Reports Fiscal 2026 Fourth Quarter and Full-Year Results
ADC THERAPEUTICS SA (ADCT)
ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates